DE eng

Search in the Catalogues and Directories

Page: 1 2 3 4
Hits 1 – 20 of 72

1
Communication Difficulties and their Association with Caregiving Burdens in Aphasic Dementia
In: Innov Aging (2021)
BASE
Show details
2
Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium.
In: Alzheimer's & dementia : the journal of the Alzheimer's Association, vol 16, iss 1 (2020)
BASE
Show details
3
Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium.
In: Alzheimer's & dementia : the journal of the Alzheimer's Association, vol 16, iss 1 (2020)
BASE
Show details
4
Speech and language therapy approaches to managing primary progressive aphasia
Volkmer, Anna; Rogalski, Emily; Henry, Maya. - : BMJ Publishing Group Ltd, 2020
BASE
Show details
5
Data from: ApoE is a correlate of phenotypic heterogeneity in Alzheimer’s disease in a national cohort ...
BASE
Show details
6
Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium
In: Alzheimers Dement (2020)
BASE
Show details
7
APOE is a correlate of phenotypic heterogeneity in Alzheimer disease in a national cohort
In: Neurology (2020)
BASE
Show details
8
Familial language network vulnerability in primary progressive aphasia
In: Neurology (2020)
BASE
Show details
9
Montreal Cognitive Assessment (MoCA) Performance and Domain-Specific Index Scores in Amnestic versus Aphasic Dementia
In: J Int Neuropsychol Soc (2020)
BASE
Show details
10
Differential neurocognitive network perturbation in amnestic and aphasic Alzheimer disease
Martersteck, Adam; Sridhar, Jaiashre; Rader, Benjamin. - : Lippincott Williams & Wilkins, 2020
BASE
Show details
11
Genetic screen in a large series of patients with primary progressive aphasia
BASE
Show details
12
Perturbations of Language Network Connectivity in Primary Progressive Aphasia
In: Cortex (2019)
BASE
Show details
13
Clinical and cortical decline in the aphasic variant of Alzheimer’s disease
BASE
Show details
14
Neuropathologic basis of in vivo cortical atrophy in the aphasic variant of Alzheimer’s disease
In: Brain Pathol (2019)
BASE
Show details
15
Word comprehension in temporal cortex and Wernicke area: A PPA perspective
Mesulam, M.-Marsel; Rader, Benjamin M.; Sridhar, Jaiashre. - : Lippincott Williams & Wilkins, 2019
BASE
Show details
16
Speech and language therapy approaches to managing primary progressive aphasia
BASE
Show details
17
Verb-argument integration in primary progressive aphasia: Real-time argument access and selection
In: Neuropsychologia (2019)
BASE
Show details
18
Prevalence of amyloid‐β pathology in distinct variants of primary progressive aphasia
In: ISSN: 0364-5134 ; EISSN: 1531-8249 ; Annals of Neurology ; https://hal-univ-fcomte.archives-ouvertes.fr/hal-03630161 ; Annals of Neurology, Wiley, 2018, 84 (5), pp.729-740. ⟨10.1002/ana.25333⟩ (2018)
BASE
Show details
19
Prevalence of amyloid‐β pathology in distinct variants of primary progressive aphasia
Bergeron, David; Gorno-Tempini, Maria,; Rabinovici, Gil,; Santos-Santos, Miguel,; Seeley, William; Miller, Bruce,; Pijnenburg, Yolande; Keulen, M Antoinette; Groot, Colin; Van Berckel, Bart,; Van Der Flier, Wiesje,; Scheltens, Philip; Rohrer, Jonathan,; Warren, Jason,; Schott, Jonathan,; Fox, Nick,; Sánchez-Valle, Raquel; Grau-Rivera, Oriol; Gelpi, Ellen; Seelaar, Harro; Papma, Janne,; Van Swieten, John,; Hodges, John,; Leyton, Cristian,; Piguet, Olivier; Rogalski, Emily,; Mesulam, Marsel,; Koric, Lejla; Nora, Kristensen; Pariente, Jeéreémie; Dickerson, Bradford; Mackenzie, Ian,; Hsiung, Ging-Yuek,; Belliard, Serge; Irwin, David,; Wolk, David,; Grossman, Murray; Jones, Matthew; Harris, Jennifer; Mann, David; Snowden, Julie,; Chrem-Mendez, Patricio; Calandri, Ismael,; Amengual, Alejandra,; Miguet-Alfonsi, Carole; Magnin, Eloi; Magnani, Giuseppe; Santangelo, Roberto; Deramecourt, Vincent; Pasquier, Florence; Mattsson, Niklas; Nilsson, Christer; Hansson, Oskar; Keith, Julia; Masellis, Mario; Black, Sandra,; Matías-Guiu, Jordi,; Cabrera-Martin, María-Nieves; Paquet, Claire; Dumurgier, Julien; Teichmann, Marc; Sarazin, Marie; Bottlaender, Michel; Dubois, Bruno; Rowe, Christopher,; Villemagne, Victor,; Vandenberghe, Rik; Granadillo, Elias; Teng, Edmond; Mendez, Mario; Meyer, Philipp,; Frings, Lars; Lleó, Alberto; Blesa, Rafael; Fortea, Juan; Seo, Sang Won; Diehl-Schmid, Janine; Grimmer, Timo; Frederiksen, Kristian Steen; Sánchez-Juan, Pascual; Chételat, Gaël; Jansen, Willemijn; Bouchard, Rémi,; Laforce, Robert Jr; Visser, Pieter Jelle; Ossenkoppele, Rik
In: ISSN: 0364-5134 ; EISSN: 1531-8249 ; Annals of Neurology ; https://www.hal.inserm.fr/inserm-02749861 ; Annals of Neurology, Wiley, 2018, 84 (5), pp.729-740. ⟨10.1002/ana.25333⟩ (2018)
Abstract: International audience ; Objective: To estimate the prevalence of amyloid positivity, defined by positron emission tomography (PET)/cerebrospinal fluid (CSF) biomarkers and/or neuropathological examination, in primary progressive aphasia (PPA) variants.Methods: We conducted a meta-analysis with individual participant data from 1,251 patients diagnosed with PPA (including logopenic [lvPPA, n = 443], nonfluent [nfvPPA, n = 333], semantic [svPPA, n = 401], and mixed/unclassifiable [n = 74] variants of PPA) from 36 centers, with a measure of amyloid-β pathology (CSF [n = 600], PET [n = 366], and/or autopsy [n = 378]) available. The estimated prevalence of amyloid positivity according to PPA variant, age, and apolipoprotein E (ApoE) ε4 status was determined using generalized estimating equation models.Results: Amyloid-β positivity was more prevalent in lvPPA (86%) than in nfvPPA (20%) or svPPA (16%; p < 0.001). Prevalence of amyloid-β positivity increased with age in nfvPPA (from 10% at age 50 years to 27% at age 80 years, p < 0.01) and svPPA (from 6% at age 50 years to 32% at age 80 years, p < 0.001), but not in lvPPA (p = 0.94). Across PPA variants, ApoE ε4 carriers were more often amyloid-β positive (58.0%) than noncarriers (35.0%, p < 0.001). Autopsy data revealed Alzheimer disease pathology as the most common pathologic diagnosis in lvPPA (76%), frontotemporal lobar degeneration-TDP-43 in svPPA (80%), and frontotemporal lobar degeneration-TDP-43/tau in nfvPPA (64%).Interpretation: This study shows that the current PPA classification system helps to predict underlying pathology across different cohorts and clinical settings, and suggests that age and ApoE genotype should be considered when interpreting amyloid-β biomarkers in PPA patients. Ann Neurol 2018;84:737-748.
Keyword: [SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]
URL: https://doi.org/10.1002/ana.25333
https://www.hal.inserm.fr/inserm-02749861
BASE
Hide details
20
A Life Participation Approach to Primary Progressive Aphasia Intervention
BASE
Show details

Page: 1 2 3 4

Catalogues
0
0
2
0
0
0
0
Bibliographies
1
0
0
0
0
0
0
0
0
Linked Open Data catalogues
0
Online resources
0
0
0
0
Open access documents
70
0
0
0
0
© 2013 - 2024 Lin|gu|is|tik | Imprint | Privacy Policy | Datenschutzeinstellungen ändern